Answers are grounded in this paper and cite their sources.
Malignant struma ovarii is an exceedingly rare pathology with a paucity of established criteria regarding management and surveillance with recommendations largely based on case reports and retrospective data. Many authors have supported stratification of malignant struma ovarii into low vs high-risk disease with more conservative management reserved for those deemed low-risk. Here we present a unique case of recurrent metastatic malignant struma ovarii after surveillance was undertaken in the setting of initially low-risk disease.
No takes yet. Share an insight, caveat, or question.
Brown et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: